AVH Chart, page-653

This RCEL is a volatile beast but I guess if the gaps higher are larger than the gaps lower that's all we can ask.

I'm no expert in this field so have a couple of questions:

1. Why would there be such aggressive buying leading into their report? Is it possible their sales team are making good progress which will translate to a better than expected figure (or at least better than expected projections)?

2. Is there much competition out there in their space and if so is this a concern? I'd imagine hospitals will only been choosing one such product?

3. Is there any risk that their technology has issues going forward or has it gone beyond that stage?

Thanks for anyone that has the time to answer and apologies if these questions have previously been addressed - if that's the case I'd appreciate any links you could provide.

Thanks